575 related articles for article (PubMed ID: 26549248)
1. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis--A Comprehensive Review and Guide to Therapy. I. Systemic Disease.
Kohanim S; Palioura S; Saeed HN; Akpek EK; Amescua G; Basu S; Blomquist PH; Bouchard CS; Dart JK; Gai X; Gomes JA; Gregory DG; Iyer G; Jacobs DS; Johnson AJ; Kinoshita S; Mantagos IS; Mehta JS; Perez VL; Pflugfelder SC; Sangwan VS; Sippel KC; Sotozono C; Srinivasan B; Tan DT; Tandon R; Tseng SC; Ueta M; Chodosh J
Ocul Surf; 2016 Jan; 14(1):2-19. PubMed ID: 26549248
[TBL] [Abstract][Full Text] [Related]
2. Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease.
Kohanim S; Palioura S; Saeed HN; Akpek EK; Amescua G; Basu S; Blomquist PH; Bouchard CS; Dart JK; Gai X; Gomes JA; Gregory DG; Iyer G; Jacobs DS; Johnson AJ; Kinoshita S; Mantagos IS; Mehta JS; Perez VL; Pflugfelder SC; Sangwan VS; Sippel KC; Sotozono C; Srinivasan B; Tan DT; Tandon R; Tseng SC; Ueta M; Chodosh J
Ocul Surf; 2016 Apr; 14(2):168-88. PubMed ID: 26882981
[TBL] [Abstract][Full Text] [Related]
3. UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.
Creamer D; Walsh SA; Dziewulski P; Exton LS; Lee HY; Dart JKG; Setterfield J; Bunker CB; Ardern-Jones MR; Watson KMT; Wong GAE; Philippidou M; Vercueil A; Martin RV; Williams G; Shah M; Brown D; Williams P; Mohd Mustapa MF; Smith CH
J Plast Reconstr Aesthet Surg; 2016 Jun; 69(6):e119-e153. PubMed ID: 27287213
[TBL] [Abstract][Full Text] [Related]
4. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update.
Dodiuk-Gad RP; Chung WH; Valeyrie-Allanore L; Shear NH
Am J Clin Dermatol; 2015 Dec; 16(6):475-93. PubMed ID: 26481651
[TBL] [Abstract][Full Text] [Related]
5. [Stevens-Johnson syndrome and toxic epidermal necrolysis--updates and innovations].
Halevy S
Harefuah; 2010 Mar; 149(3):186-90, 193. PubMed ID: 20684173
[TBL] [Abstract][Full Text] [Related]
6. Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases.
Abe R
J Dermatol Sci; 2008 Dec; 52(3):151-9. PubMed ID: 18657400
[TBL] [Abstract][Full Text] [Related]
7. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
[TBL] [Abstract][Full Text] [Related]
8. [News in severe clinical adverse drug reactions: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)].
Martínez-Cabriales SA; Gómez-Flores M; Ocampo-Candiani J
Gac Med Mex; 2015; 151(6):777-87. PubMed ID: 26581536
[TBL] [Abstract][Full Text] [Related]
9. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
Sane SP; Bhatt AD
J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
[TBL] [Abstract][Full Text] [Related]
11. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Harr T; French LE
Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study.
Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK
BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410
[TBL] [Abstract][Full Text] [Related]
13. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
[TBL] [Abstract][Full Text] [Related]
14. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding.
French LE; Trent JT; Kerdel FA
Int Immunopharmacol; 2006 Apr; 6(4):543-9. PubMed ID: 16504917
[TBL] [Abstract][Full Text] [Related]
15. Burn unit care of Stevens Johnson syndrome/toxic epidermal necrolysis: A survey.
Le HG; Saeed H; Mantagos IS; Mitchell CM; Goverman J; Chodosh J
Burns; 2016 Jun; 42(4):830-5. PubMed ID: 26810444
[TBL] [Abstract][Full Text] [Related]
16. Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Van Batavia JP; Chu DI; Long CJ; Jen M; Canning DA; Weiss DA
J Pediatr Urol; 2017 Oct; 13(5):490.e1-490.e7. PubMed ID: 28314701
[TBL] [Abstract][Full Text] [Related]
17. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.
Schneider JA; Cohen PR
Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.
Hasegawa A; Abe R
F1000Res; 2020; 9():. PubMed ID: 32595945
[TBL] [Abstract][Full Text] [Related]
19. Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN): could retinoids play a causative role?
Mawson AR; Eriator I; Karre S
Med Sci Monit; 2015 Jan; 21():133-43. PubMed ID: 25579087
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
Fritsch PO; Sidoroff A
Am J Clin Dermatol; 2000; 1(6):349-60. PubMed ID: 11702611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
